Purchase Order 75N94023P00523
- Not listed
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,600.56 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNA scope probes to the NIH campus in Bethesda, Maryland with performance from September 8 through September 16, 2016. As the largest biomedical research agency in the world, the NIH and...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $3,857.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a division of Bio-Techne Corporation, doing business as Bio-Techne. The contract is for the delivery of RNAscope probes, reagent kits, and related products to support research efforts being conducted at the agency's Bethesda, Maryland campus. As the leading...
- This contract award is to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation, by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $5,110.00 firm-fixed-price purchase order is for ACD's proprietary RNAscope technology and related products to support biomedical research efforts across various NIH institutes and other federal agencies. ACD's expertise in RNA detection has made it a valuable...
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...
- The National Institute of Child Health and Human Development (NICHD), a civilian agency, awarded a firm-fixed-price purchase order contract worth $24,970.34 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the supply of reagent kits and probes, specifically ACD's proprietary RNAscope technology, to support biomedical research efforts across various NIH institutes. ACD has been a longstanding partner for federal research...
- The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $16,732 firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) for gene expression analysis study services. The contract, which does not have a set-aside designation, will support the agency's research efforts in areas such as cancer, infectious diseases, neuroscience, and genomics. As a molecular diagnostics company specializing in RNA...
- This federal contract award, valued at $10,912.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of reagents and kits, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. Through this firm-fixed-price purchase order, ACD will...
- This is a $20,000.00 firm-fixed-price purchase order contract awarded to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute on Drug Abuse, a component of the National Institutes of Health (NIH). The contract is for the delivery of ACD's proprietary RNAscope reagent kits and probes for research applications. ACD, a subsidiary of Bio-Techne Corporation, is a leading provider of molecular diagnostic tools and has been awarded over 50 prime federal contracts, primarily from NIH and...
- This firm-fixed-price $33,717 federal contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of ACD's proprietary RNAscope technology, which enables the visualization and quantification of RNA biomarkers. This technology will be used to analyze human pluripotent stem cell-derived...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $34,831.75 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for RNA probes. Advanced Cell Diagnostics, Inc. will deliver the requested RNA probes to support research efforts at the Bethesda, Maryland facility under this three-month contract ending September 30, 2023. As a leading biotechnology company, Bio-Techne Corporation is the parent company of Advanced Cell Diagnostics,...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,435 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation, also doing business as Bio-Techne. The contract is for the delivery of RNAscope reagents, kits, and specific probes to support NICHD's research efforts. As the leading federal sponsor of biomedical research, NIH aims to uncover new knowledge that will lead to better health for everyone and Advanced Cell Diagnostics' products will enable NICHD grantees to conduct advanced molecular pathology studies. The one-year contract runs from July 2022 through July 2023 and calls for the delivery of RNAscope products to support NICHD's research programs in Newark, California.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 7/18/23 |